HOLX — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates HOLX as Neutral with 69% confidence in the Healthcare sector.
AI Analysis Summary
HOLX presents significant risks due to extreme leverage and deteriorating earnings despite modest technical and sector advantages.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade B — 65/100
- Ray Dalio (Macro/Risk Parity): Grade B — 65/100
Consensus: Bearish
Price Intelligence
- Current price: $76.01
- Price target: $73.55 (-3.2%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
HOLX is in the “Quality Cash Generators” cluster alongside YUM, WYNN, USB, VICI, V (96 stocks total). 2 of 96 peers are currently bullish.